Compare IVVD & ETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IVVD | ETO |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 437.1M | 471.2M |
| IPO Year | 2021 | 2004 |
| Metric | IVVD | ETO |
|---|---|---|
| Price | $1.63 | $29.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.75 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 32.0K |
| Earning Date | 04-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $25,384,000.00 | N/A |
| Revenue This Year | $107.86 | N/A |
| Revenue Next Year | $146.53 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $20.05 |
| 52 Week High | $3.07 | $31.11 |
| Indicator | IVVD | ETO |
|---|---|---|
| Relative Strength Index (RSI) | 41.64 | 37.91 |
| Support Level | $1.41 | $27.05 |
| Resistance Level | $2.01 | $29.43 |
| Average True Range (ATR) | 0.10 | 0.48 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 46.30 | 20.12 |
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Eaton Vance Tax-advtgd Global Divid Oppo is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. The portfolio of investments consists of capital markets, chemicals, diversified, beverages, banks, electric utilities, oil, gas and consumable fuels, personal products, and other areas.